A table showing vaccine effectiveness against omicron variants BA.1 and BA.2.
Note: Vaccine effectiveness against symptomatic disease following BA.2 infection was analyzed in a test-negative case control design, as compared to the Omicron BA.1 sub-lineage. Analysis combined all vaccines.